New SEC Form D filing
Kaigene, Inc., 2026-10-14
A new SEC Form D private-offering notice from Rockville, MD, a $73,350,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Biotech developing antibody therapeutics for autoimmune diseases via its PDEG platform that degrades pathogenic antibodies
Filed 2026-10-14Filed to raise $73,350,000First money in 2026-09-30Raised so far $54,958,229HQ (as filed) Rockville, MDSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified kaigene.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- OS Therapies Inc, 2026-10-23, $12.3M, Grasonville, MD
- Ensho Therapeutics, Inc., 2026-10-15, $15.6M, Woodcliff Lake, NJ
- MATIUM INC., 2026-10-13, $5M, Millersville, MD
- Renue Life Sciences, Inc., 2026-10-14, $3M, San Carlos, CA
- ColoWatch, Inc., 2026-10-08, $3M, Gaithersburg, MD
- Myris Therapeutics, Inc., 2026-10-14, $4.5M, Sharpsburg, PA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.